Accelerating the development of targeted cancer treatments
Orano Med looked for solutions using AI and computational tools to test in silico the affinity between tumour targets and targeting molecules, to speed up the development of new cancer treatments.
- Sector
- Healthcare & oncology
- TRL
- TRL 3-4 and above
- Deadline
- 6 December 2022 (closed)
Why an innovation call?
Recent progress in artificial intelligence has made it possible to predict the 3D conformation of molecules. The affinity between the targeting molecule and the tumour target is an essential criterion of efficacy, and it depends to a large extent on the 3D configuration of both molecules.
Orano Med develops vectorised radiotherapy treatments in-house, but affinity tests are currently performed in vitro and then in vivo, which is very time-consuming and expensive.
To fight cancers that have reached a therapeutic dead end, Orano Med seeks to accelerate the development of new treatments by identifying solutions to test this affinity in silico, in order to pre-select candidates for in vivo testing.
Am I eligible?
Orano Med called on entrepreneurs, startups, and research and innovation centres that can help to speed up its research.
Startups, SMEs and research
Applications from startups, SMEs, university projects and innovation centres were accepted.
At least TRL 3-4
Your solution has reached experimental proof-of-concept, and you are able to test data.
What will you benefit from?
Selected applicants had access to real data, experts and a path to partnership with Orano Med.
Real data
Test your solution and validate it on real in vivo data.
Experts and network
Connect and get visibility with biotech experts (board members) and Orano Med's ecosystem.
Global Summit access
The best startups were offered a Hello Tomorrow Global Summit pass, with travel expenses covered by Orano in line with its travel policy.
Partnership
If testing on real data is a success, the opportunity to develop a co-financed POC with Orano Med's team.
How the call ran
From the Ask Me Anything webinar to the testing phase with Orano Med's team.
Ask Me Anything webinar
The Orano Med team answered all questions about the challenge.
Applications close
Last day to submit an application.
Alignment calls
Orano Med and the selected startups align on goals and expectations.
Meet Orano Med at the Global Summit
Selected startups meet the Orano Med team at the Hello Tomorrow Global Summit.
Testing phase
Experimental data is provided to validate the models, and the collaboration with Orano Med begins.
In collaboration with
Orano Med
Created in 2009 as AREVA Med (renamed Orano Med in 2018) to develop new cancer therapies, it ran the world's first clinical trials with ²¹²Pb between 2012 and 2014. Today, Orano Med has more than 80 employees in France and the USA.
Hello Tomorrow Consulting
Hello Tomorrow Consulting connects corporates and public institutions with innovative deep tech startups through tailored scouting programmes. We help organisations discover emerging technologies and connect directly with the startups shaping the future.
Your questions about the startup call
Who could apply?
Startups, SMEs, university projects and innovation centres at TRL 3-4 (experimental proof-of-concept) or above, able to test data.
What problem did Orano Med want to solve?
Testing in silico the affinity between tumour targets and targeting molecules, to pre-select candidates for in vivo testing and speed up the development of new cancer treatments.
What did selected startups get?
Access to real in vivo data, biotech experts and Orano Med's ecosystem, a Global Summit pass for the best startups, and the opportunity to develop a co-financed POC with Orano Med.
Who can I contact for more information?
Our project lead, Marwan Aïtomar (marwan.aitomar@hello-tomorrow.org).
Explore past calls
See the open innovation calls we have run with corporations and public partners.
Deep Scale Climate Tech Accelerator
A climate tech acceleration programme bridging Latin America with global deep tech ecosystems, with lab access in Chile and international expansion support.
L'Oréal GSI Startup Call 2026
L'Oréal's Green Sciences Incubator and Genopole looked for alternative carbon sources and sustainable ingredients for cosmetics.
ASML Emerging Innovator Award 2026
A global contest by ASML for startups building breakthrough technologies for next-generation high-tech and complex systems.
ESA Φ-lab Grand Marathon 2025
AI-enabled Earth Observation concepts to protect civilians in conflict and disaster zones. Up to €215K in cumulative prizes.
Applications are closed
The Orano Med call looked for in silico tools to speed up targeted cancer treatments. Discover our open calls or contact us to hear about the next ones.